Electrical Industry Drug-Free “Alliance”

1. Electrical Industry Drug-Free “Alliance” ScreenSafe Inc. Program Administrators 1-877-SCREEN-9 Employee Resource Systems, Inc. Members Assistance Program 1-800-292-2780

2. The Alliance • The Central Illinois National Electrical Contractors’ Association and Local 34, I.B.E.W. have formed a partnership to address the problems caused by drug and alcohol abuse

3. Alliance Goals and Objectives • Recognition of the problem; • Development of a comprehensive policy; • Educate Participants; • Promote the Member Assistance Program, MAP; • Implement a fair and respectful drug testing program that conforms to Federal drug testing standards.

4. Policy Requirements and Prohibitions • All Participants will be selected randomly at least once over a 2 year period through the 50% pool. • Participants who complete the testing process will not be returned to the 50% pool. • Every Participant will be in an ongoing 10% pool.

5. Policy Requirements and Prohibitions • The use of alcohol or drugs by employees during working hours on the job site or on company property (including company vehicles) is absolutely prohibited. • Participants are required to submit to drug and/or alcohol testing in accordance with this policy.

6. Policy Requirements and Prohibitions • No participant will be tested for alcohol unless a reasonable suspicion exists that the person is under the influence of alcohol, or they are involved in an OSHA recordable on the job accident. • Participants subject to this policy continue to have access to the usual protections provided as part of their union membership.

7. Testing Procedures-Reasonable suspicion/for cause • A supervisor calls Screensafe for paperwork and procedure. • A supervisor must confront you. • A supervisor must drive you to the test site. • A supervisor must find a way home for you. • The designated representative is notified of result. • If a participant is negative any lost wages are reimbursed. • If the participant is positive you are considered non-compliant.

8. Testing Procedures • Names picked from the random pool. • ScreenSafe calls referral to find out where union member is working. • Designated (Company or Union) Representative called and informed to expect a fax regarding participants being tested.

9. Testing Procedures • Forms sent to Designated Representative: • Testing Procedures for the Electrical Industry Drug Free Alliance • List of Collection Sites • By the end of the business day, the Designated Representative informs participant that his/her name has been selected.

10. Testing Procedures • Participants given one hour off with regular wages and fringe benefits paid by Employer(excludes accelerated testing). • Participants are given until end of next day to take test.

11. At The Collection Site • The Alliance Drug Test Information and Instruction Sheet • Authorization for Consent to Drug Analysis and Authorization of Release of Results for Testing • Release of Information Signed for MRO, MAP and ScreenSafe

12. At The Collection Site • Participant signs consent forms • Collection Site technician faxes Consent and Release form back to ScreenSafe.

13. Testing Procedures – Safeguards • Urine samples separated into two containers at time of collection(in case you disagree with the result the SAME specimen will be tested). • Other forms of testing for participants with confirmed medical conditions • Blind testing

14. Testing Procedures - Safeguards • Integrity of specimens insured by utilization of one collection procedure at all sites • All labs have DHHS certification • All positives confirmed by GCMS(Gas Chromatography) • MRO verifies all questionable non-negative results

15. Testing Procedures • If the test is negative, no further action is taken. • If the test is positive for any reason, the Medical Review Officer (MRO) calls participant to validate reason for positive. • If the MRO can not reach the participant they are considered non-compliant • If no valid reason found, participant is non-compliant.

16. Medical Review Office • Verifies your prescription • It must be your prescription and must have been filled before the date of your test. • If your prescription is verified by the MRO a negative result is reported out. • Any participant can call the MRO to try to verify a result. • Any participant can re-test the ORIGINAL specimen at a substantial cost. If the re-tested specimen is negative the participant will be refunded.

17. Policy Violations • Policy Violations can include; • Having a positive test result. • Failing to take a test as scheduled • Failing to keep a scheduled appointment with MAP or • Failing to participate in and/or complete the assigned treatment or education program

18. Policy Violations • Policy Violations can include (continued); • Substituting another substance or specimen • Providing a dilute specimen(an observed drop will then be necessary)if the second specimen is dilute it is a violation. • Providing a urine specimen which shows the presence of an adulterant

19. Consequences • Upon a first notice of non-compliance; • Participant will be referred to the MAP for evaluation • Participant must complete recommended treatment or education program • Participant will be returned to work prior to program completion • The participant will be placed in a one year accelerated testing program.

20. Consequences • Upon a first notice of non-compliance; • Participant may wait out 30 days. During this 30 day wait out the participant may not work, must have negative drug test to return and will be terminated from the contractor.

21. Consequences • ScreenSafe will let the Designated Representative know that the participant is unavailable. • ScreenSafe will let the referral hall know that the participant is unavailable. • Participants will receive written notices confirming their test results and providing them with information to assist them in returning to compliance.

22. Consequences • Upon a second notice of unavailability; • Participant will be referred to the MAP for evaluation • Participant must complete recommended treatment or education program • Participant may be returned to work prior to program completion • The participant will be placed in a one year accelerated testing program.

23. Consequences • Upon a third notice of unavailability within a two-year period from the preceding (second); • Participant will be referred to the MAP for evaluation • Participant must complete recommended treatment or education program • Participant may be returned to work prior to program completion • The participant will be placed in a one year accelerated testing program. • The participant will be required to sign a "Last Chance Agreement" between participant and the Alliance.

24. Consequences • Upon a fourth positive test within a two-year period from the preceding (third); • Participant will be referred to the MAP for evaluation • Participant must complete recommended treatment or education program • Participant may be returned to work prior to program completion • The participant will be placed in a one year accelerated testing program. (continued)

25. Consequences • The participant shall be terminated from employment and, if the referral procedure policy provides, is ineligible for referral until participant has satisfactorily completed the assigned treatment or other program. • The participant will be required to sign a "Last Chance Agreement" between him/herself and the Alliance.

26. Returning and Continuing Compliance • Follow-up testing • Following MAP recommendations If you do not finish the recommendations of the Map you will be considered NON-COMPLIANT.

27. Testing Occasions - Portability • These provisions will apply to those individuals working under the portability rules. • All traveling craftpersons will be subject to: • Initial testing • Random testing – 10% pool

28. Testing Occasions - Portability • Craftsperson will be allowed to report to work immediately after providing a urine specimen for testing. • A positive test for any policy violation will result in immediate termination from company. • A Craftsperson will be out of that jurisdiction for a period of 30 days upon returning to that jurisdiction the Craftsperson must take a negative drop.

29. Testing Occasions - Portability Participants who are called to work assignments that are anticipated to last three (3) days or less are subject to the Alliance drug-free workplace policy, but may be exempt from the drug-testing program.